Plasmid News and Research

RSS
A quantitative assessment of SARS-CoV-2 bioaerosol production

A quantitative assessment of SARS-CoV-2 bioaerosol production

Researchers develop a transferrable and integrative type I CRISPR-based platform to edit superbugs

Researchers develop a transferrable and integrative type I CRISPR-based platform to edit superbugs

Evaluation of a synthetic DNA SARS-CoV-2 vaccine INO-4800 using a nonhuman primate model

Evaluation of a synthetic DNA SARS-CoV-2 vaccine INO-4800 using a nonhuman primate model

Curia to Acquire US-based LakePharma, Expanding End-to-End R&D Capabilities and Scale for Biologics

Curia to Acquire US-based LakePharma, Expanding End-to-End R&D Capabilities and Scale for Biologics

Use of nanotherapeutics in treating coronavirus diseases

Use of nanotherapeutics in treating coronavirus diseases

COVID-e-Vax DNA vaccine candidate elicits robust immune responses in preclinical trials

COVID-e-Vax DNA vaccine candidate elicits robust immune responses in preclinical trials

International travelers often return home with new bacterial strains, confirms study

International travelers often return home with new bacterial strains, confirms study

Researchers identify kite-shaped molecules that block SARS-CoV-2 cell entry after attachment

Researchers identify kite-shaped molecules that block SARS-CoV-2 cell entry after attachment

Harnessing DNA’s properties to craft “‘topologically tunable” DNA-based materials

Harnessing DNA’s properties to craft “‘topologically tunable” DNA-based materials

Stabilizing mutations in SARS-CoV-2 immunogens improve vaccine design

Stabilizing mutations in SARS-CoV-2 immunogens improve vaccine design

Phase 2 trial shows INO-4800 SARS-CoV-2 DNA vaccine safe and tolerable in adults

Phase 2 trial shows INO-4800 SARS-CoV-2 DNA vaccine safe and tolerable in adults

An intranasal COVID-19 vaccine elicits long-lasting immunity against SARS-CoV-2 variants in vivo

An intranasal COVID-19 vaccine elicits long-lasting immunity against SARS-CoV-2 variants in vivo

A new strain of common probiotic can potentially be more effective at protecting infant health

A new strain of common probiotic can potentially be more effective at protecting infant health

New COVID-19 vaccine could provide protection against existing and future strains of coronaviruses

New COVID-19 vaccine could provide protection against existing and future strains of coronaviruses

Candidate coronavirus vaccines show promising results in early animal testing

Candidate coronavirus vaccines show promising results in early animal testing

New polypeptide could provide universal protection against coronaviruses

New polypeptide could provide universal protection against coronaviruses

South Africa SARS-CoV-2 variant B.1.351 easily escapes Sputnik vaccine

South Africa SARS-CoV-2 variant B.1.351 easily escapes Sputnik vaccine

Developing a COVID-19 vaccine using inactivated E. coli

Developing a COVID-19 vaccine using inactivated E. coli

New study maps SARS-CoV-2 and host protein interactions in detail

New study maps SARS-CoV-2 and host protein interactions in detail

GMP-Ready Helper Plasmids for AAV Production

GMP-Ready Helper Plasmids for AAV Production